Monoclonal antibody, inhibiting the enzymatic activity of vascular endothelial lipase
US9701757B2 · kind B2 · utility
2Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 12, 2014 |
| Grant date | Jul 11, 2017 |
| Priority date | — |
| Expiry date | Mar 12, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y301/01004
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided is a monoclonal antibody or a fragment thereof that selectively inhibits the enzymatic activity of vascular endothelial lipase and pharmaceutical compositions containing the same as an active ingredient useful for the treatment of arteriosclerosis or metabolic syndrome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.